Publicações

Randomized Phase Iii Study of Lenalidomide Versus Placebo in Rbc Transfusion-Dependent Patients With Lower-Risk Non-Del(5Q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents

AuthID
P-00K-T5A

Author(s)

Santini, V

Giagounidis, A

Mufti, GJ

Buckstein, R

Mittelman, M

Platzbecker, U

[+2]·

del Canizo, C

Gattermann, N

Ozawa, K

Risueno, A

MacBeth, KJ

Zhong, JH

Seguy, F

Hoenekopp, A

Beach, CL

Fenaux, P

View all authors

Tipo de Documento

Article

Year published

2016

Publicado

in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X

Volume: 34, Número: 25, Páginas: 2988-+ (11)

Indexing

Wos^®

Scopus^®

Crossref^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1200/jco.2015.66.0118

SCOPUS: 2-s2.0-84983628285

Wos: WOS:000382470100009

Source Identifiers

ISSN: 0732-183X

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

All authors

Name Order	Nome	Name Order	Nome	Name Order	Nome
1	Santini, V;	2	Almeida, A;	3	Giagounidis, A;
4	Groepper, S;	5	Jonasova, A;	6	Vey, N;
7	Mufti, GJ;	8	Buckstein, R;	9	Mittelman, M;
10	Platzbecker, U;	11	Shpilberg, O;	12	Ram, R;
13	del Canizo, C;	14	Gattermann, N;	15	Ozawa, K;
16	Risueno, A;	17	MacBeth, KJ;	18	Zhong, JH;
19	Seguy, F;	20	Hoenekopp, A;	21	Beach, CL;
22	Fenaux, P;

Randomized Phase Iii Study of Lenalidomide Versus Placebo in Rbc Transfusion-Dependent Patients With Lower-Risk Non-Del(5Q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Randomized Phase Iii Study of Lenalidomide Versus Placebo in Rbc Transfusion-Dependent Patients With Lower-Risk Non-Del(5Q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents

Links Úteis

Ajuda